Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Homology Medicines nominates in vivo gene editing development candidate for PKU

Jan. 8, 2019

Phase I results reported for oral ferroportin inhibitor VIT-2763

Jan. 7, 2019

Positive topline results presented from first cohort of phase I/II study of DTX-401

Jan. 7, 2019

Horizon Pharma and HemoShear Therapeutics to jointly discover therapeutics for gout

Jan. 4, 2019

Arcturus Therapeutics nominates ARCT-810 as development candidate for OTC deficiency

Jan. 2, 2019

Amgen develops anti-GIPR antibody

Dec. 31, 2018

FDA approves sNDA to expand the age range for Ravicti oral liquid to include newborns

Dec. 28, 2018

Glucose-lowering agents revealed in Daiichi Sankyo patent

Dec. 28, 2018

University of Pisa researchers describe GLP-1 receptor agonists

Dec. 28, 2018

Novel more soluble ferrostatin-1 analogues inhibiting ferroptosis in vivo

Dec. 28, 2018

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...